These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26740635)

  • 1. Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
    Gori M; Gupta DK; Claggett B; Selvin E; Folsom AR; Matsushita K; Bello NA; Cheng S; Shah A; Skali H; Vardeny O; Ni H; Ballantyne CM; Astor BC; Klein BE; Aguilar D; Solomon SD
    Diabetes Care; 2016 May; 39(5):677-85. PubMed ID: 26740635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
    Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
    Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ishigami J; Kim Y; Sang Y; Menez SP; Grams ME; Skali H; Shah AM; Hoogeveen RC; Selvin E; Solomon SD; Ballantyne CM; Coresh J; Matsushita K
    Clin Chem; 2021 Jan; 67(1):298-307. PubMed ID: 33418586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes.
    Tang O; Daya N; Matsushita K; Coresh J; Sharrett AR; Hoogeveen R; Jia X; Windham BG; Ballantyne C; Selvin E
    Diabetes Care; 2020 Jun; 43(6):1200-1208. PubMed ID: 32161049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
    Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Cardiovascular Biomarkers in the Population.
    Neumann JT; Twerenbold R; Weimann J; Ballantyne CM; Benjamin EJ; Costanzo S; de Lemos JA; deFilippi CR; Di Castelnuovo A; Donfrancesco C; Dörr M; Eggers KM; Engström G; Felix SB; Ferrario MM; Gansevoort RT; Giampaoli S; Giedraitis V; Hedberg P; Iacoviello L; Jørgensen T; Kee F; Koenig W; Kuulasmaa K; Lewis JR; Lorenz T; Lyngbakken MN; Magnussen C; Melander O; Nauck M; Niiranen TJ; Nilsson PM; Olsen MH; Omland T; Oskarsson V; Palmieri L; Peters A; Prince RL; Qaderi V; Vasan RS; Salomaa V; Sans S; Smith JG; Söderberg S; Thorand B; Tonkin AM; Tunstall-Pedoe H; Veronesi G; Watanabe T; Watanabe M; Zeiher AM; Zeller T; Blankenberg S; Ojeda F
    JAMA; 2024 Jun; 331(22):1898-1909. PubMed ID: 38739396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults.
    Gore MO; Ayers CR; Khera A; deFilippi CR; Wang TJ; Seliger SL; Nambi V; Selvin E; Berry JD; Hundley WG; Budoff M; Greenland P; Drazner MH; Ballantyne CM; Levine BD; de Lemos JA
    J Am Heart Assoc; 2020 Aug; 9(15):e015410. PubMed ID: 32698652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
    Matsushita K; Sang Y; Ballew SH; Astor BC; Hoogeveen RC; Solomon SD; Ballantyne CM; Woodward M; Coresh J
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1770-7. PubMed ID: 24876355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.
    Whelton SP; McEvoy JW; Lazo M; Coresh J; Ballantyne CM; Selvin E
    Diabetes Care; 2017 Feb; 40(2):261-269. PubMed ID: 28108537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.
    Nambi V; Liu X; Chambless LE; de Lemos JA; Virani SS; Agarwal S; Boerwinkle E; Hoogeveen RC; Aguilar D; Astor BC; Srinivas PR; Deswal A; Mosley TH; Coresh J; Folsom AR; Heiss G; Ballantyne CM
    Clin Chem; 2013 Dec; 59(12):1802-10. PubMed ID: 24036936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study.
    Everett BM; Cook NR; Magnone MC; Bobadilla M; Kim E; Rifai N; Ridker PM; Pradhan AD
    Circulation; 2011 Jun; 123(24):2811-8. PubMed ID: 21632491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
    Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.
    Agarwala A; Virani S; Couper D; Chambless L; Boerwinkle E; Astor BC; Hoogeveen RC; Coresh J; Sharrett AR; Folsom AR; Mosley T; Ballantyne CM; Nambi V
    Atherosclerosis; 2016 Oct; 253():156-163. PubMed ID: 27665201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
    Saunders JT; Nambi V; de Lemos JA; Chambless LE; Virani SS; Boerwinkle E; Hoogeveen RC; Liu X; Astor BC; Mosley TH; Folsom AR; Heiss G; Coresh J; Ballantyne CM
    Circulation; 2011 Apr; 123(13):1367-76. PubMed ID: 21422391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
    Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
    Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
    JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.